Volume 30, Number 6—June 2024
Research
Trends in Nationally Notifiable Infectious Diseases in Humans and Animals during COVID-19 Pandemic, South Korea
Taehee Chang, Sung-il Cho, Dae sung Yoo, and Kyung-Duk Min
Table 3
Annual medical expenses due to infectious diseases in a study of trends in nationally notifiable infectious diseases in humans and animals during COVID-19 pandemic, South Korea*
| Diseases | Expenses, in million USD |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Observed, 2018 |
Observed, 2019 |
Estimated, 2020 |
Observed, 2020 (% difference)† |
Estimated, 2021 |
Observed, 2021 (% difference)‡ |
|||||
| Lower 95% | Average | Upper 95% | Lower 95% | Average | Upper 95% | |||||
| Respiratory | ||||||||||
| Varicella | 5,399 | 5,590 | 3,704 | 7,153 | 13,548 | 2,675 (−62.61) | 2,692 | 6,559 | 16,001 | 1,971 (−69.95) |
| Pertussis | 544 | 298 | 44 | 380 | 1,171 | 42 (−88.98) | 13 | 409 | 1,900 | 6 (−98.65) |
| Mumps | 1,283 | 1,445 | 1,203 | 1,552 | 2,189 | 790 (−49.08) | 1,066 | 1,532 | 2,203 | 775 (−49.42) |
| IPD | 1,988 | 1,686 | 1,305 | 2,920 | 6,437 | 1,360 (−53.41) | 1,305 | 3,370 | 8,717 | 1,116 (−66.87) |
| Scarlet fever | 1,283 | 691 | 182 | 465 | 947 | 317 (−31.80) | 28 | 124 | 567 | 154 (24.27) |
| Tuberculosis | 61,241 | 63,535 | 42,695 | 48,705 | 55,593 | 53,681 (10.21) | 48,536 | 59,956 | 74,117 | 54,324 (−9.39) |
| Subtotal |
71,738 |
73,244 |
49,134 |
61,174 |
79,886 |
58,864 (−3.77) |
53,640 |
71,951 |
103,505 |
58,345 (−18.91) |
| Gastrointestinal | ||||||||||
| Typhoid | 153 | 41 | 6 | 17 | 62 | 27 (89.81) | 5 | 22 | 102 | 41 (90.625) |
| Shigellosis | 36 | 49 | 6 | 22 | 40 | 12 (−46.86) | 3 | 21 | 126 | 15 (−28.06) |
| Hepatitis A | 2,248 | 27,297 | 1,477 | 6,193 | 22,857 | 4,820 (−22.17) | 1,466 | 9,407 | 60,328 | 9,769 (3.85) |
| EHEC | 120 | 157 | 94 | 176 | 275 | 364 (106.61) | 86 | 184 | 388 | 244 (33.06) |
| Subtotal |
2,557 |
27,544 |
1,583 |
6,408 |
23,234 |
5,223 (−18.49) |
1,560 |
9,633 |
60,945 |
10,070 (4.53) |
| Total | 74,295 | 100,788 | 50,717 | 67,582 | 103,120 | 64,087 (−5.17) | 55,201 | 81,584 | 164,450 | 68,415 (−16.14) |
*EHEC, enterohemorrhagic Escherichia coli; IPD, invasive pneumococcal disease; USD, US dollars. †Difference from average estimates for 2020. ‡Difference from average estimates for 2021.
Page created: May 02, 2024
Page updated: May 22, 2024
Page reviewed: May 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.